(HealthDay News) -- Here are the latest clinical trials,
This study is for people aged 12 to 45 with moderate-to-severe
facial acne. Participants may qualify for compensation up to
The research site is in Bryan, Texas.
This study will evaluate kd-247, a humanized monoclonal
antibody, in people with HIV-1 infection who lack symptoms and are
not receiving current antiretroviral therapy.
The research site is in Tamarac, Fla.
This study will compare different FDA-approved treatment options
for acute migraines.
The research site is in Charleston, S.C.
ClinicalConnection.com. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.